Insud Pharma drives health innovation with new round of startup programme #CHEMOSTART!

Wednesday, November 7, 2018

  • This year, the programme is focused on women’s health, biosimilars and new technologies
  • The winning projects will receive coaching, mentoring and financial backing

The pharmaceutical group Insud Pharma has just kicked off the second round of its startup programme #CHEMOSTART!, which aims to help get innovative health projects off the ground and offer additional support to projects which are already up and running.

The programme is open to all health-related projects, although this second round is focused particularly on women’s health, biosimilar medicines, treatment adherence, precision medicine, artificial intelligence and new technologies applied to the healthcare sector.

The winning projects will receive mentoring and coaching from a panel of experts, a coworking space to develop their projects, at least six months’ support and guidance and financial backing tailored to the project’s requirements.

Insud Pharma will also be acting as an investor in any projects that are in keeping with its core strategic areas of activity.

To raise awareness of this programme, the website now features an area dedicated especially to researchers and entrepreneurs who are interested in taking part:

Within this area, there is a specific space for the submission of applications, where participants can submit their projects for the programme quickly and easily:

The application period is now open and will close on 5 December 2018. Once all the applications are in, each proposal will be evaluated individually and shortlisted entrants will be invited to present their projects at a Pitch Day in Madrid in January 2019.

The projects will be evaluated by an external panel of experts specialising in the fields of entrepreneurship and health.

For participating entrepreneurs, the key programme dates are as follows:

Insud Pharma is launching this second round of #CHEMOSTART! on the back of the extremely successful first round of the programme. Last year, the winning projects were:

  • BIOHOPE: In vitro diagnostic test (immunobiogram) for the treatment of inflammatory diseases, by Isabel Portero.
  • BIRDI: Device for the treatment of urinary incontinence, by Luis Carlos Fernández.
  • MEDICSEN: Artificial non-invasive pancreas for diabetes treatment, by Eduardo W. Jorgensen.

Insud Pharma is always seeking passion and disruptive talent with the potential to revolutionise the healthcare sector and make people’s lives easier. But they also know how tough it can be to get a project off the ground, which is why they want to change the rules, monitoring and supporting entrepreneurial projects right from the outset.